Skip to main content

Table 5 Accessibility, fetal fraction, and earliest gestational age at which cfDNA screening can be offered (n = 188)

From: Obstetrical provider knowledge and attitudes towards cell–free DNA screening: results of a cross-sectional national survey

Question:

OB/GYN (n = 114)

% [95% CI]

MFM (n = 29)

% [95% CI]

GP (n = 31)

% [95%CI]

MW (n = 14)

% [95% CI]

p-value

Correctly identified that cfDNA is not widely accessible and free of cost to every woman in Canada.

89.5% [82.3–94.0]

89.7% [71.8–96.7]

77.4% [59.1–89.0]

85.7% [55.7–96.6]

p = 0.405

Correctly identified that 10 weeks is the earliest gestational age at which cfDNA can be offered.

63.7% [54.4–72.1]

100.0%

54.8% [37.1–71.5]

50.0% [25.1–74.9]

p = 0.036

Correctly identified the following factors as associated with low fetal fraction:

 Maternal weight

44.7% [35.8–54.0]

75.9% [56.8–88.3]

38.7% [23.2–57.0]

21.4% [6.7–50.9]

p = 0.002

 Crown-Rump Length

14.0% [8.7–21.8]

51.7% [33.7–69.3]

9.7% [3.1–26.6]

0.0%

p = 0.000

 Gestational age

64.9% [55.6–73.2]

96.6% [78.4–99.5]

41.9% [25.8–60.0]

28.6% [10.6–57.3]

p = 0.000

Correctly identified the following factors as NOT associated with low fetal fraction:

 Fetal sex

97.4% [92.1–99.2]

93.1% [75.6–98.3]

96.8% [79.6–99.6]

100.0%

p = 0.601

 Parity

99.1% [93.9–99.9]

100.0%

100.0%

92.9% [60.8–99.1]

p = 0.133

Reported not knowing which factors are associated with low fetal fraction.

27.2% [19.8–36.2]

0.0%

48.4% [31.3–65.8]

64.3% [36.5–84.9]

p = 0.000

  1. *Abbreviations: OB/GYN Obstetrician/Gynecologist, MFM Maternal Fetal Medicine Specialist, GP General Practitioner, MW Midwife